Managing heart failure with reduced ejection fraction merged with myocardial infarction with non-obstructive coronary arteries: a case report
We managed a patient with HFrEF and MINOCA. Although CCBs are not routinely recommended for HFrEF, we added dihydropyridine CCBs to treat CSA/VSA based on comprehensive diagnostic procedures. This approach sedated chest pain and may have contributed to her EF improvement. Detailed examinations and tailored treatment strategies might be helpful for HF treatment.
Authors
- Masanobu Ishii (ORCID: https://orcid.org/0000-0003-4137-9136)
- Kenichi Tsujita (ORCID: https://orcid.org/0000-0002-4314-259X)
- So Ikebe
- Eiichiro Yamamoto (ORCID: https://orcid.org/0000-0001-8411-3448)
- Masahiro Yamamoto (ORCID: https://orcid.org/0000-0001-8310-9228)
Institutions
- Kumamoto University Hospital (JP)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1093/ehjcr/ytae540
- Citations
- 1
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.40